Find your path to Ori
253 people in our graph share verified history with Ori — schools, employers, funds. One of them is your warm intro.
Assaf ArakiunlockedOri: together at Ben-Gurion University of the Negev (2001–2005)
×3Ori: together at Duke University - The Fuqua School of Business
×6Ori: together at London Business School
Ori: together at Duke University, Office of Licensing and Ventures
About
Ori Warshavsky is Chief Operating Officer for US Operations at PolyPid Ltd., a biopharmaceutical company developing drug delivery technologies, where he oversees the strategy, execution, and growth of the company's US presence. He has more than 15 years of experience in the biotech and pharmaceutical industry, with a background spanning engineering, science, marketing, business development, and investor relations. He is also a member at G-CMO.
Executive at PolyPid
Intro paths
→
In turn, Ori can intro founders to PolyPid's investors below.
PolyPid's investors · 1
Co-founders at PolyPid
NE
Noam EmanuelExecutive Officer, Director
AW
Amir WeisbergExecutive Officer, Director
Experience
- G-CMOMembercurrent2026 — present
- PolyPid Ltd.Chief Operating Officer - US Operationscurrent2022 — presentSummit, NJ
- PolyPid Ltd.Vice President Marketing2020 — 2022
- Teva PharmaceuticalsSenior Director, US Oncology Marketing - Biosimilars2019 — 2020
- Teva PharmaceuticalsSenior Director, Strategic Projects and Alliances2018New Jersey
- Teva PharmaceuticalsSenior Director, Head of Market Access, Teva Canada2016 — 2018Montreal, Canada
- Teva PharmaceuticalsChief of Staff to the CEO and President of Teva's Global Generics Medicine (GGM)2014 — 2016Greater Philadelphia Area
- Teva Pharmaceutical Industries Ltd.Director, Corporate Development, Strategy and Innovation2013 — 2014Greater Philadelphia Area
- Teva Pharmaceutical Industries Ltd.Associate Director, Corporate Strategy2012Greater Philadelphia Area
- Teva PharmaceuticalsSenior Manager2011 — 2012
- Teva PharmaceuticalsStrategic Planning Analyst2010 — 2011
- GeNO, LLCBusiness Development Consultant2009 — 2010
- Duke University, Office of Licensing and VenturesTechnology Assessment Associate2008 — 2009
- MacrogenicsAssociate Scientist II / Business Development Associate2006 — 2008
- XTL BiopharmaceuticalsResearch Associate2004 — 2005
Skills & more
LeadershipStrategic Thinking4Negotiation2Strategy36Management8Strategic Planning3Analysis1COOsInternational Business2Strategic Leadership2Startups2Marketing
+12 more
Leadership DevelopmentC-level supportC SuiteMarketing StrategyExecutive ManagementBiotechnologyPharmaceutical IndustryMarket ResearchMedical DevicesBusiness DevelopmentMarket AnalysisCompetitive AnalysisLanguages English · Hebrew
From Ori's professional profile.
Frequently asked questions
- Who is Ori Warshavsky?
- Ori Warshavsky is Chief Operating Officer for US Operations at PolyPid Ltd., a biopharmaceutical company developing drug delivery technologies, where he oversees the strategy, execution, and growth of the company's US presence. He has more than 15 years of experience in the biotech and pharmaceutical industry, with a background spanning engineering, science, marketing, business development, and investor relations. He is also a member at G-CMO.
- Where does Ori Warshavsky work?
- Ori Warshavsky is Executive at PolyPid.
- Where did Ori Warshavsky go to school?
- Ori Warshavsky studied at Duke University - The Fuqua School of Business (MBA, Strategy); London Business School (Commerical Leadership Academy); McGill Executive Institute.
Same school
Also attended Duke University - The Fuqua School of Business335
Dave BlivinMANAGING PARTNER at Cottonwood Technology FundBrooke BalcomBoard Member at CincyTechChad SummeBoard Member at CincyTechTracie RotterPartner, Platform at Lux CapitalUlili OnovakpuriManaging Partner at Kapor CapitalLindsay MehtaDirector, Investor Relations & Marketing at JMI Equity
+ 329 more
Also attended London Business School906
Patrick ClaessenPartner at Cottonwood Technology FundDominic JacquessonInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesMatt CherianVenture Partner at Monta Vista CapitalAkshat GoenkaInvestor at Moonfire VenturesGiuseppe IademarcoHead of Global Partnership at P101 Ventures
+ 900 more
Also attended McGill Executive Institute4
Also attended Ben-Gurion University of the Negev216
Assaf ArakiInvestment Director at Intel CapitalJonathan PacificiVenture Capitalist, Entrepreneur and Community Leader; General Partner at Sixth Millennium Venture Partners at Sixth Millennium Venture Partners Management, LlcYair SchindelCo-Founder & Managing Partner at aMoonShimon TsentsiperVenture Partner at Key1 CapitalRoy KimchiSenior Associate at Square Peg CapitalAtad PeledPartner at Red Dot Capital Partners
+ 210 more
Shared employers
Also worked at G-CMO7
Yoni HeilbronnManaging Partner at IL VenturesNoa SchumanInvestor at theDOCKMerav MelubanChief Marketing Officer at Viola VenturesSharon ReisnerCMO at AU10TIXHila Shitrit NissimCMO at PlainIDUri Bar-JosephCo-Founder and CPO at Formationscorp
+ 1 more
Also worked at PolyPid Ltd.1
Also worked at Teva Pharmaceuticals52
Catherine Pearce, DHSc, MBAAdvisor at CincyTechElad BaronInvestment Professional at Key1 CapitalElaine ShannonPresident, Global Supply & Quality at Takeda VenturesRiki MozesVice President, Chief People Officer at Jerusalem Venture Partners (JVP)Jill DeSimoneDigital Pharma Advisor at Excelerate Health VenturesPerry NisenExecutive Advisor, Private Equity at Sofinnova Ventures
+ 46 more
